UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome

Nature (London), 2018-12, Vol.564 (7735), p.273-277

2018

Volltextzugriff (PDF)

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

Haematologica (Roma), 2021-04, Vol.106 (4), p.978-986

2021

Volltextzugriff (PDF)

CD19 CAR-targeted T cells induce long-term remission and B Cell Aplasia in an immunocompetent mouse model of B cell acute lymphoblastic leukemia

PloS one, 2013-04, Vol.8 (4), p.e61338

2013

Volltextzugriff (PDF)

CAR models: next-generation CAR modifications for enhanced T-cell function

Molecular therapy. Oncolytics, 2016, Vol.3 (C), p.16014-16014, Article 16014

2016

Volltextzugriff (PDF)

NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient

Haematologica (Roma), 2018-09, Vol.103 (9), p.e424-e426

2018

Volltextzugriff (PDF)

Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes

The Journal of clinical investigation, 2021-01, Vol.131 (2), p.1-10

2021

Volltextzugriff (PDF)

4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells

Journal for immunotherapy of cancer, 2021-10, Vol.9 (10), p.e003354

2021

Volltextzugriff (PDF)

Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies

International journal of hematology, 2014-04, Vol.99 (4), p.361-371

2014

Volltextzugriff (PDF)

Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage

Journal of biomedical science, 2024-07, Vol.31 (1), p.1-13, Article 68

2024

Volltextzugriff (PDF)

VDJServer: A Cloud-Based Analysis Portal and Data Commons for Immune Repertoire Sequences and Rearrangements

Frontiers in immunology, 2018-05, Vol.9, p.976-976

2018

Volltextzugriff (PDF)

Biology and clinical application of CAR T cells for B cell malignancies

International Journal of Hematology, 2016-07, Vol.104 (1), p.6-17

2016

Volltextzugriff (PDF)

CAR T cells find strength in polyfunction

Blood, 2018-08, Vol.132 (8), p.769-770

Davila, Marco L.

2018

Volltextzugriff (PDF)

Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell Malignancies

Stem cells (Dayton, Ohio), 2018-01, Vol.36 (1), p.36-44

2018

Volltextzugriff (PDF)

Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

Molecular therapy. Oncolytics, 2023-12, Vol.31, p.100751-100751, Article 100751

2023

Volltextzugriff (PDF)

Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism

Cell, 2018-12, Vol.175 (7), p.1780-1795.e19

2018

Volltextzugriff (PDF)

Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma

Blood, 2021-05, Vol.137 (19), p.2621-2633

2021

Volltextzugriff (PDF)

CAR T-cell hematotoxicity: is inflammation the key?

Blood, 2021-12, Vol.138 (24), p.2447-2448

2021

Volltextzugriff (PDF)

Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy

Journal for immunotherapy of cancer, 2022-07, Vol.10 (7), p.e004938

2022

Volltextzugriff (PDF)

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Science translational medicine, 2013-03, Vol.5 (177), p.177ra38

2013

Volltextzugriff (PDF)

CD19-Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia

Clinical advances in hematology & oncology, 2016-10, Vol.14 (10), p.802-808

2016

Volltextzugriff (PDF)

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Science translational medicine, 2014-02, Vol.6 (224), p.224ra25

2014

Volltextzugriff (PDF)

Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma

EJHaem, 2022-02, Vol.3 (1), p.223-227

2022

Volltextzugriff (PDF)

Advances in CAR T cell clinical development

Best practice & research. Clinical haematology, 2021-09, Vol.34 (3), p.101307-101307, Article 101307

2021

Volltextzugriff (PDF)

Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma

International journal of radiation oncology, biology, physics, 2019-12, Vol.105 (5), p.1012-1021

2019

Volltextzugriff (PDF)

1 – 25 von 225

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

CD19 CAR-targeted T cells induce long-term remission and B Cell Aplasia in an immunocompetent mouse model of B cell acute lymphoblastic leukemia

CAR models: next-generation CAR modifications for enhanced T-cell function

NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient

Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes

4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells

Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies

Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage

VDJServer: A Cloud-Based Analysis Portal and Data Commons for Immune Repertoire Sequences and Rearrangements

Biology and clinical application of CAR T cells for B cell malignancies

CAR T cells find strength in polyfunction

Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell Malignancies

Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism

Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma

CAR T-cell hematotoxicity: is inflammation the key?

Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

CD19-Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma

Advances in CAR T cell clinical development

Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Suchergebnisse filtern